vs
AXCELIS TECHNOLOGIES INC（ACLS）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
AXCELIS TECHNOLOGIES INC的季度营收约是CORCEPT THERAPEUTICS INC的1.2倍（$238.3M vs $202.1M），AXCELIS TECHNOLOGIES INC净利率更高（14.4% vs 12.0%，领先2.4%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs -5.6%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $-8.9M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs -2.8%）
Axcelis Technologies是一家美国半导体设备供应商，1995年成立，总部位于美国马萨诸塞州贝弗利。公司面向全球半导体制造行业，从事半导体生产核心设备的设计、制造及服务，主营产品包括高中电流、高能离子注入系统以及半导体芯片制造用固化系统。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
ACLS vs CORT — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $238.3M | $202.1M |
| 净利润 | $34.3M | $24.3M |
| 毛利率 | 47.0% | 98.7% |
| 营业利润率 | 15.2% | 2.2% |
| 净利率 | 14.4% | 12.0% |
| 营收同比 | -5.6% | 11.1% |
| 净利润同比 | -31.3% | -21.0% |
| 每股收益（稀释后） | $1.11 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $238.3M | $202.1M | ||
| Q3 25 | $213.6M | $207.6M | ||
| Q2 25 | $194.5M | $194.4M | ||
| Q1 25 | $192.6M | $157.2M | ||
| Q4 24 | $252.4M | $181.9M | ||
| Q3 24 | $256.6M | $182.5M | ||
| Q2 24 | $256.5M | $163.8M | ||
| Q1 24 | $252.4M | $146.8M |
| Q4 25 | $34.3M | $24.3M | ||
| Q3 25 | $26.0M | $19.7M | ||
| Q2 25 | $31.4M | $35.1M | ||
| Q1 25 | $28.6M | $20.5M | ||
| Q4 24 | $50.0M | $30.7M | ||
| Q3 24 | $48.6M | $47.2M | ||
| Q2 24 | $50.9M | $35.5M | ||
| Q1 24 | $51.6M | $27.8M |
| Q4 25 | 47.0% | 98.7% | ||
| Q3 25 | 41.6% | 97.8% | ||
| Q2 25 | 44.9% | 98.2% | ||
| Q1 25 | 46.1% | 98.5% | ||
| Q4 24 | 46.0% | 98.4% | ||
| Q3 24 | 42.9% | 98.4% | ||
| Q2 24 | 43.8% | 98.5% | ||
| Q1 24 | 46.0% | 98.3% |
| Q4 25 | 15.2% | 2.2% | ||
| Q3 25 | 11.7% | 4.9% | ||
| Q2 25 | 14.9% | 13.7% | ||
| Q1 25 | 15.1% | 2.2% | ||
| Q4 24 | 21.6% | 13.9% | ||
| Q3 24 | 18.3% | 25.5% | ||
| Q2 24 | 20.6% | 21.7% | ||
| Q1 24 | 22.4% | 20.1% |
| Q4 25 | 14.4% | 12.0% | ||
| Q3 25 | 12.2% | 9.5% | ||
| Q2 25 | 16.1% | 18.1% | ||
| Q1 25 | 14.8% | 13.1% | ||
| Q4 24 | 19.8% | 16.9% | ||
| Q3 24 | 18.9% | 25.9% | ||
| Q2 24 | 19.8% | 21.7% | ||
| Q1 24 | 20.4% | 18.9% |
| Q4 25 | $1.11 | $0.20 | ||
| Q3 25 | $0.83 | $0.16 | ||
| Q2 25 | $0.98 | $0.29 | ||
| Q1 25 | $0.88 | $0.17 | ||
| Q4 24 | $1.54 | $0.25 | ||
| Q3 24 | $1.49 | $0.41 | ||
| Q2 24 | $1.55 | $0.32 | ||
| Q1 24 | $1.57 | $0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $374.3M | $372.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.0B | $647.8M |
| 总资产 | $1.4B | $836.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $374.3M | $372.2M | ||
| Q3 25 | $449.6M | $421.7M | ||
| Q2 25 | $549.8M | $342.2M | ||
| Q1 25 | $587.1M | $322.8M | ||
| Q4 24 | $571.3M | $383.3M | ||
| Q3 24 | $579.4M | $380.3M | ||
| Q2 24 | $548.3M | $473.2M | ||
| Q1 24 | $530.2M | $410.8M |
| Q4 25 | $1.0B | $647.8M | ||
| Q3 25 | $1.0B | $631.9M | ||
| Q2 25 | $1.0B | $635.8M | ||
| Q1 25 | $1.0B | $683.3M | ||
| Q4 24 | $1.0B | $679.6M | ||
| Q3 24 | $975.6M | $638.8M | ||
| Q2 24 | $934.9M | $596.2M | ||
| Q1 24 | $901.7M | $547.9M |
| Q4 25 | $1.4B | $836.7M | ||
| Q3 25 | $1.4B | $823.6M | ||
| Q2 25 | $1.3B | $801.7M | ||
| Q1 25 | $1.3B | $846.5M | ||
| Q4 24 | $1.3B | $840.6M | ||
| Q3 24 | $1.3B | $784.3M | ||
| Q2 24 | $1.3B | $714.6M | ||
| Q1 24 | $1.3B | $655.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-6.6M | $38.4M |
| 自由现金流经营现金流 - 资本支出 | $-8.9M | $38.4M |
| 自由现金流率自由现金流/营收 | -3.7% | 19.0% |
| 资本支出强度资本支出/营收 | 1.0% | 0.0% |
| 现金转化率经营现金流/净利润 | -0.19× | 1.58× |
| 过去12个月自由现金流最近4个季度 | $107.0M | — |
8季度趋势，按日历期对齐
| Q4 25 | $-6.6M | $38.4M | ||
| Q3 25 | $45.4M | $54.5M | ||
| Q2 25 | $39.7M | $43.9M | ||
| Q1 25 | $39.8M | $5.1M | ||
| Q4 24 | $12.8M | $59.3M | ||
| Q3 24 | $45.7M | $73.8M | ||
| Q2 24 | $40.1M | $41.2M | ||
| Q1 24 | $42.2M | $23.8M |
| Q4 25 | $-8.9M | $38.4M | ||
| Q3 25 | $43.3M | — | ||
| Q2 25 | $37.7M | $43.9M | ||
| Q1 25 | $34.8M | $5.0M | ||
| Q4 24 | $8.1M | $59.2M | ||
| Q3 24 | $41.8M | $72.2M | ||
| Q2 24 | $38.1M | $40.8M | ||
| Q1 24 | $40.6M | — |
| Q4 25 | -3.7% | 19.0% | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 19.4% | 22.6% | ||
| Q1 25 | 18.1% | 3.2% | ||
| Q4 24 | 3.2% | 32.5% | ||
| Q3 24 | 16.3% | 39.5% | ||
| Q2 24 | 14.8% | 24.9% | ||
| Q1 24 | 16.1% | — |
| Q4 25 | 1.0% | 0.0% | ||
| Q3 25 | 0.9% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 2.6% | 0.1% | ||
| Q4 24 | 1.8% | 0.1% | ||
| Q3 24 | 1.5% | 0.9% | ||
| Q2 24 | 0.8% | 0.3% | ||
| Q1 24 | 0.6% | 0.0% |
| Q4 25 | -0.19× | 1.58× | ||
| Q3 25 | 1.75× | 2.77× | ||
| Q2 25 | 1.27× | 1.25× | ||
| Q1 25 | 1.39× | 0.25× | ||
| Q4 24 | 0.26× | 1.93× | ||
| Q3 24 | 0.94× | 1.56× | ||
| Q2 24 | 0.79× | 1.16× | ||
| Q1 24 | 0.82× | 0.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACLS
| Products | $224.6M | 94% |
| Services | $13.7M | 6% |
CORT
暂无分部数据
